SLC45A2-CCDC125 Fusion FISH Probe
The SLC45A2-CCDC125 Fusion FISH Probe is used to confirm a fusion of the SLC45A2 and CCDC125 genes. The fusion of the SLC45A2 and CCDC125 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC45A2-CCDC125-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC45A2-CCDC125-20-AQAQ | 20 (40 μL) | 200 μL |
|
SLC45A2 Gene Summary
This gene encodes a transporter protein that mediates melanin synthesis. The protein is expressed in a high percentage of melanoma cell lines. Mutations in this gene are a cause of oculocutaneous albinism type 4, and polymorphisms in this gene are associated with variations in skin and hair color. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Gene Name: Solute Carrier Family 45 Member 2
Chromosome: CHR5: 33944720 -33984780
Locus: 5p13.2
CCDC125 Gene Summary
The Coiled-coil Domain Containing 125 (CCDC125) gene is located on chr5 :68576518-68616410 at 5q13.2.
Gene Name: Coiled-coil Domain Containing 125
Chromosome: CHR5: 68576518 -68616410
Locus: 5q13.2
Gene Diseases
The SLC45A2 CCDC125 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|